# Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor

> **NCT07681375** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **DexCom, Inc.** · enrollment: 45 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Basal insulin
- **DEVICE:** Dexcom Continuous Glucose Monitoring (CGM)

## Key facts

- **NCT ID:** NCT07681375
- **Lead sponsor:** DexCom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-11
- **Primary completion:** 2026-01-16
- **Final completion:** 2027-01-15
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681375, "Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07681375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*